drugset / Trial / NCT07323329

Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization

NCT07323329

Phase 2/3 Recruiting 165 enrolled Beni-Suef University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate the role of Somatropin and Dehydroepiandrosterone (DHEA) on ovarian reserve parameters and intracytoplasmic sperm injection (ICSI) outcome in poor ovarian responder. The main question it aims to answer is: Which intervention is more effective in increasing number and size of follicles? Participants will be followed 1 month before starting induction in growth hormone and 12 weeks for DHEA and through intracytoplasmic sperm injection (ICSI) cycle.

Timeline

Start
2025-10-10
Primary completion
2026-10-15
Completion
2026-11-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydroepiandrosterone Other / unclassified 50 mg
Subject Somatropin Protein / enzyme biologic 4 iu Subcutaneous
Background folic acid Other / unclassified 400 ug

Indications